- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 11, 2019
Emerging Company Profile
Twentyeight-Seven’s bet on RNA-binding proteins
Twentyeight-Seven is capitalizing on the emerging biology of RNA-binding proteins by targeting their interactions with non-coding RNAs
BioCentury | May 19, 2016
Distillery Therapeutics
Therapeutics: Sirtuin 6 (SIRT6); lin-28 homolog B (LIN28B)
Items per page:
1 - 8 of 8